Literature DB >> 12417512

Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study.

Franco Roviello1, Daniele Marrelli, Paolo Morgagni, Giovanni de Manzoni, Alberto Di Leo, Carla Vindigni, Luca Saragoni, Anna Tomezzoli, Hayato Kurihara.   

Abstract

BACKGROUND: The survival benefit of extended lymphadenectomy in the surgical treatment of gastric cancer is still being debated. The aim of this longitudinal multicenter study was to evaluate long-term survival in a group of patients with involvement of second level lymph nodes, which would not have been removed in the case of a limited lymphadenectomy. Results were compared with those in patients with involvement of first level lymph nodes.
METHODS: Between 1991 and 1997, 451 patients with primary gastric cancer underwent curative resection with extended lymphadenectomy at three surgical departments in Italy according to the rules of the Japanese Research Society for Gastric Cancer.
RESULTS: In 451 cases treated by extended lymphadenectomy, morbidity and mortality rates were 17.1% and 2%, respectively. In 126 patients (27.9%) (group A), metastases were found in lymph node stations 7 to 12; 109 patients (24.2%) had metastases confined to the first level (group B). Lymph node stations 7 and 8 showed the highest incidence of metastases in the second level (17.1% and 12.4%, respectively). A significant difference in 5-year survival was observed between group A and group B (32% vs. 54%; P =.0005). This difference disappeared when cases were stratified according to the number of positive lymph nodes. By multivariate analysis, only the number of positive lymph nodes (relative risk, 1.8; P <.0001) and the depth of invasion (relative risk, 2.1; P <.0001), but not the level of involved nodes, showed to be independent predictors of poor prognosis.
CONCLUSIONS: Japanese-type extended lymphadenectomy yields low morbidity and mortality rates if performed in specialized centers. This procedure could provide a good probability of long-term survival, even for patients with involvement of regional lymph nodes.

Entities:  

Mesh:

Year:  2002        PMID: 12417512     DOI: 10.1007/bf02557527

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  37 in total

1.  The sentinel node biopsy in early gastric cancer: a preliminary study.

Authors:  Gianni Mura; Alessio Vagliasindi; Massimo Framarini; Paolo Mazza; Gabriele Solfrini; Giorgio M Verdecchia
Journal:  Langenbecks Arch Surg       Date:  2006-03-09       Impact factor: 3.445

2.  D1 versus D2 dissection in gastric carcinoma: Evaluation of postoperative mortality and complications.

Authors:  Veli Vural; Barış Saylam; Bülent Çomçalı; Arife Polat Düzgün; Mehmet Vasfi Özer; Faruk Coşkun
Journal:  Ulus Cerrahi Derg       Date:  2013-03-01

3.  Reoperation for early postoperative complications after gastric cancer surgery in a Chinese hospital.

Authors:  Birendra Kumar Sah; Ming-Min Chen; Min Yan; Zheng-Gang Zhu
Journal:  World J Gastroenterol       Date:  2010-01-07       Impact factor: 5.742

Review 4.  Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer.

Authors:  Zhen Wang; Jun-Qiang Chen; Yun-Fei Cao
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 5.  Lymphadenectomy: state of the art.

Authors:  Daniele Marrelli; Lorenzo De Franco; Livio Iudici; Karol Polom; Franco Roviello
Journal:  Transl Gastroenterol Hepatol       Date:  2017-01-17

Review 6.  Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives.

Authors:  Valentina Mengardo; Maria Bencivenga; Jacopo Weindelmayer; Michele Pavarana; Simone Giacopuzzi; Giovanni de Manzoni
Journal:  Updates Surg       Date:  2018-05-30

Review 7.  Multimodal treatment of gastric cancer in the west: Where are we going?

Authors:  Daniele Marrelli; Karol Polom; Giovanni de Manzoni; Paolo Morgagni; Gian Luca Baiocchi; Franco Roviello
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

8.  Modified radical lymphadenectomy (D1.5) for T2-3 gastric cancer.

Authors:  Takashi Ichikura; Kentaro Chochi; Hidekazu Sugasawa; Hidetaka Mochizuki
Journal:  Langenbecks Arch Surg       Date:  2005-07-22       Impact factor: 3.445

9.  Resection line involvement after gastric cancer surgery: clinical outcome in nonsurgically retreated patients.

Authors:  P Morgagni; D Garcea; D Marrelli; G De Manzoni; G Natalini; H Kurihara; A Marchet; L Saragoni; E Scarpi; C Pedrazzani; A Di Leo; F De Santis; V Panizzo; D Nitti; F Roviello
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

10.  Gastric cancer surgery: Billroth I or Billroth II for distal gastrectomy?

Authors:  Birendra K Sah; Ming-Min Chen; Min Yan; Zheng-Gang Zhu
Journal:  BMC Cancer       Date:  2009-12-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.